Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Baudax Bio Inc is a biotechnology business based in the US. Baudax Bio shares (BXRX) are listed on the NASDAQ and all prices are listed in US Dollars. Baudax Bio employs 57 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Active traders
Our top pick for
Beginners
Our top pick for
Building a portfolio
| Latest market close | $0.20 |
|---|---|
| 52-week range | $0.19 - $2.12 |
| 50-day moving average | $0.39 |
| 200-day moving average | $0.67 |
| Wall St. target price | $1.83 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.05 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.2018 from 2022-01-14
| 1 week (2022-01-10) | -2.28% |
|---|---|
| 1 month (2021-12-17) | -41.84% |
| 3 months (2021-10-15) | -63.64% |
| 6 months (2021-07-16) | -67.07% |
| 1 year (2021-01-15) | -84.48% |
|---|---|
| 2 years (2020-01-17) | -97.27% |
| 3 years (2019-01-13) | N/A |
| 5 years (2017-01-13) | N/A |
| Revenue TTM | $756,000 |
|---|---|
| Gross profit TTM | $-1,239,000 |
| Return on assets TTM | -53.3% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | N/A |
| Market capitalisation | $17.7 million |
TTM: trailing 12 months
We're not expecting Baudax Bio to pay a dividend over the next 12 months.
Over the last 12 months, Baudax Bio's shares have ranged in value from as little as $0.1915 up to $2.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Baudax Bio's is 2.0031. This would suggest that Baudax Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Baudax Bio, Inc. , a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. .
Donut earns up to 10% APY, but you must have an iOS device.
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.